Drug profile · INN
sotatercept
WINREVAIR
sotatercept (WINREVAIR) is a inhibin beta a chain inhibitor.
EMA: approved PMDA: approved Cardiovascular system (C02) C02KX06
Patents linked 0
Pipeline programs 9
News articles 0
Drug details — sotatercept
- Class
- Cardiovascular system (C02)
- Route
- —
- Patents
- 0
- Programs
- 9
- Data quality
- 0.83
Quick answer
sotatercept (WINREVAIR) is a inhibin beta a chain inhibitor.
Key facts
INN sotatercept
Brand WINREVAIR
Mechanism Inhibin beta A chain inhibitor
Target Inhibin beta A chain
Therapeutic class Cardiovascular system (C02)
ATC code C02KX06
Mechanism of action
Inhibin beta A chain inhibitor
Primary target: Inhibin beta A chain
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is sotatercept?
sotatercept (WINREVAIR) is a inhibin beta a chain inhibitor.
What is the brand name for sotatercept?
WINREVAIR is a marketed brand name for sotatercept. Check FDA Drugs@FDA for the current US label holder and prescribing information.